Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.310
+0.060 (1.41%)
At close: Dec 5, 2025, 4:00 PM EST
4.280
-0.030 (-0.70%)
After-hours: Dec 5, 2025, 7:47 PM EST
Turn Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 3.11 | 0.87 | 1.18 | 2.1 |
| Cash & Short-Term Investments | 3.11 | 0.87 | 1.18 | 2.1 |
| Cash Growth | - | -26.11% | -43.84% | - |
| Prepaid Expenses | 0.19 | 0.23 | 0.02 | 0.02 |
| Total Current Assets | 3.29 | 1.1 | 1.2 | 2.13 |
| Property, Plant & Equipment | 0.09 | 0.12 | 0.03 | 0.08 |
| Other Intangible Assets | 0.9 | 0.82 | 0.77 | 0.7 |
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 |
| Accounts Payable | 2.26 | 0.67 | 0.46 | 0.26 |
| Current Portion of Leases | 0.04 | 0.04 | 0.03 | 0.05 |
| Current Unearned Revenue | - | - | - | 1.42 |
| Total Current Liabilities | 2.31 | 0.71 | 0.49 | 1.72 |
| Long-Term Leases | 0.05 | 0.08 | - | 0.03 |
| Long-Term Unearned Revenue | 1.44 | 1.44 | 1.44 | - |
| Common Stock | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 23.22 | 19.02 | 17.51 | 18.37 |
| Retained Earnings | -22.67 | -19.2 | -17.43 | -17.22 |
| Total Liabilities & Equity | 4.3 | 2.05 | 2.01 | 2.91 |
| Total Debt | 0.09 | 0.12 | 0.03 | 0.08 |
| Net Cash (Debt) | 3.01 | 0.75 | 1.16 | 2.02 |
| Net Cash Growth | - | -34.98% | -42.76% | - |
| Net Cash Per Share | 0.11 | 0.03 | 0.04 | - |
| Filing Date Shares Outstanding | 29.45 | 26.85 | 26.49 | - |
| Total Common Shares Outstanding | 28.02 | 26.85 | 26.49 | - |
| Working Capital | 0.99 | 0.39 | 0.71 | 0.4 |
| Book Value Per Share | 0.02 | -0.01 | 0.00 | - |
| Tangible Book Value | -0.4 | -1 | -0.68 | 0.46 |
| Tangible Book Value Per Share | -0.01 | -0.04 | -0.03 | - |
| Machinery | - | - | - | 0.01 |
Source: S&P Capital IQ. Standard template.
Financial Sources.